MINERVA SURGICAL, INC.

Minerva Surgical, Inc. specializes in the design, development, and delivery of electromedical and electrosurgical systems, with a demonstrated focus on minimally invasive tissue removal technologies for gynecological applications. The company’s technical expertise centers on precision surgical devices that integrate advanced energy-based ablation, real-time imaging feedback, and ergonomic ergonomic control systems to enhance procedural safety and clinical outcomes. Their solution for the Symphion Tissue Removal System reflects deep competency in interventional surgical robotics, closed-loop aspiration control, and FDA-regulated medical device manufacturing under QSR 21 CFR Part 820. Minerva Surgical differentiates itself through rigorous adherence to sterile field protocols, biocompatible material selection, and integration with hospital information systems for procedural documentation and traceability. The contractor has delivered critical surgical equipment to the Department of Veterans Affairs, specifically supporting the Veterans Health Administration’s Women’s Health initiative by providing next-generation hysteroscopic resection systems. This engagement indicates a proven ability to meet the VA’s stringent clinical, logistical, and maintenance requirements for high-acuity surgical platforms in ambulatory and inpatient care settings. Minerva Surgical operates primarily within NAICS 334510, focusing on the electromedical apparatus manufacturing sector, with niche specialization in gynecologic surgical instrumentation. Their market positioning aligns with the growing demand for minimally invasive alternatives to traditional open surgery, particularly in women’s health and outpatient surgical centers. While one award is listed under NAICS 339112, the specific product category remains undisclosed, limiting further insight into diversification efforts. As a small business structured as a 2L entity based in Santa Clara, California, Minerva Surgical maintains a focused footprint in the federal medical technology market. The company currently holds no federal certifications, positioning it as a technically driven manufacturer reliant on product performance and regulatory compliance rather than socioeconomic program advantages. Its geographic location in Silicon Valley supports access to advanced engineering talent and medical device innovation ecosystems.